Abstract
ThyroidVol. 22, No. 6 Letter to the EditorUse of 131I-MIBG Therapy in MIBG-Positive Metastatic Medullary Thyroid CarcinomaJean-Christophe Maiza, Solange Grunenwald, Philippe Otal, Delphine Vezzosi, Antoine Bennet, and Philippe CaronJean-Christophe MaizaDepartment of Endocrinology and Metabolic Diseases, CHU Larrey, Toulouse, France.Search for more papers by this author, Solange GrunenwaldDepartment of Endocrinology and Metabolic Diseases, CHU Larrey, Toulouse, France.Search for more papers by this author, Philippe OtalDepartment of Radiology, CHU Rangueil, Toulouse, France.Search for more papers by this author, Delphine VezzosiDepartment of Endocrinology and Metabolic Diseases, CHU Larrey, Toulouse, France.Search for more papers by this author, Antoine BennetDepartment of Endocrinology and Metabolic Diseases, CHU Larrey, Toulouse, France.Search for more papers by this author, and Philippe CaronDepartment of Endocrinology and Metabolic Diseases, CHU Larrey, Toulouse, France.Search for more papers by this authorPublished Online:5 Jun 2012https://doi.org/10.1089/thy.2011.0174AboutSectionsView articleView Full TextSupplemental MaterialPDF/EPUBView Supplemental Data ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Use of 131I-MIBG Therapy in MIBG-Positive Metastatic Medullary Thyroid Carcinoma." , 22(6), pp. 654–655FiguresReferencesRelatedDetailsCited ByNuklearmedizinische Diagnostik des medullären Schilddrüsenkarzinoms29 June 2022 | Die Onkologie, Vol. 28, No. 8EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma4 September 2019 | European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, No. 1Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls5 April 2019 | BMC Cancer, Vol. 19, No. 1Current Consensus on I-131 MIBG Therapy3 May 2018 | Nuclear Medicine and Molecular Imaging, Vol. 52, No. 4Medullary Carcinoma10 March 2018Medullary Carcinoma31 May 2018Radionuclide Imaging of Medullary Thyroid Carcinoma27 December 2016Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThe American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma Samuel A. Wells, Sylvia L. Asa, Henning Dralle, Rossella Elisei, Douglas B. Evans, Robert F. Gagel, Nancy Lee, Andreas Machens, Jeffrey F. Moley, Furio Pacini, Friedhelm Raue, Karin Frank-Raue, Bruce Robinson, M. Sara Rosenthal, Massimo Santoro, Martin Schlumberger, Manisha Shah, and Steven G. Waguespack3 June 2015 | Thyroid, Vol. 25, No. 6 Volume 22Issue 6Jun 2012 InformationCopyright 2012, Mary Ann Liebert, Inc.To cite this article:Jean-Christophe Maiza, Solange Grunenwald, Philippe Otal, Delphine Vezzosi, Antoine Bennet, and Philippe Caron.Use of 131I-MIBG Therapy in MIBG-Positive Metastatic Medullary Thyroid Carcinoma.Thyroid.Jun 2012.654-655.http://doi.org/10.1089/thy.2011.0174Published in Volume: 22 Issue 6: June 5, 2012Online Ahead of Print:May 8, 2012PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
